chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered with vaccine that is past beyond the 30 day use or after manufacture date of expiry) and PRODUCT STORAGE ERROR (Vaccine was initially stored in the refrigerator on 20-Apr-2022 and administered on 24-May-2022) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033K212A and 069H21A) for COVID-19 vaccination. Previously administered products included for Drug use for unknown indication: PFIZER (Dose- 1, Batch lot number-EW0175, ROA-IM, left deltoid, Dose/Volume-0.3 ml) on 23-Jun-2021, PFIZER (Dose- 2, Batch lot number-EW0191 ROA-IM and Dose/Volume-0.3 ml) on 14-Jul-2021. Past adverse reactions to the above products included No adverse event with PFIZER and PFIZER. On 18-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 24-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 24-May-2022, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered with vaccine that is past beyond the 30 day use or after manufacture date of expiry). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was initially stored in the refrigerator on 20-Apr-2022 and administered on 24-May-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered with vaccine that is past beyond the 30 day use or after manufacture date of expiry) and PRODUCT STORAGE ERROR (Vaccine was initially stored in the refrigerator on 20-Apr-2022 and administered on 24-May-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications was provided by the reporter. Number of doses or vials administered 13 booster in 1vial. The Vial was initially stored on refrigerator on 20-Apr-2022. The vial had not undergone any temperature excursion. No treatment medications were reported
Moderna COVID-19 Vaccine EUA. Had a mild breakout of shingles three days after the vaccine.  Not my first bout of shingles and I've had the shingles shot.
Developed a lump in my eye (right) orbit which grew to 1" and had to be removed surgically on 05/19/21. Was told it was possible foreign body reaction that could relate to vaccine. Note: I contracted Covid in Nov2020 Developed another lump on left cheek in Sept 21 and attended clinic, the doctor injected dissolving agent to remove any traces of facial filler. Told possible side effect of vaccine with filler (although no fillers used in 2 years).
No adverse event; 2 patients were administered with 1st dose of Moderna COVID-19 Vaccine beyond use date/Patient number 2 received the vaccine on 6Feb2023 but the vaccine expired on 21Jan2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (2 patients were administered with 1st dose of Moderna COVID-19 Vaccine beyond use date/Patient number 2 received the vaccine on 6Feb2023 but the vaccine expired on 21Jan2023) and NO ADVERSE EVENT (No adverse event) in a 15-month-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1412B) for COVID-19 prophylaxis.     Question:Describe relevant medical history/conditions, allergy, concomitant diseases and risk factor.Answer:Ear infection, treated with Amoxicillin.  The patient's past medical history included Ear infection. Previously administered products included for Ear infection: AMOXICILLINE [AMOXICILLIN]; for Product used for unknown indication: PENTACEL and PNEUMOCOCCAL CONJUGATE VACCINE. Past adverse reactions to the above products included No adverse event with AMOXICILLINE [AMOXICILLIN], PENTACEL and PNEUMOCOCCAL CONJUGATE VACCINE.    On 06-Feb-2023, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 06-Feb-2023,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (2 patients were administered with 1st dose of Moderna COVID-19 Vaccine beyond use date/Patient number 2 received the vaccine on 6Feb2023 but the vaccine expired on 21Jan2023). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (2 patients were administered with 1st dose of Moderna COVID-19 Vaccine beyond use date/Patient number 2 received the vaccine on 6Feb2023 but the vaccine expired on 21Jan2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (2 patients were administered with 1st dose of Moderna COVID-19 Vaccine beyond use date/Patient number 2 received the vaccine on 6Feb2023 but the vaccine expired on 21Jan2023).    Concomitant medication was not provided. Treatment medication information was not provided by the reporter. It was reported that patient number 2 did not experienced any AEs after getting the vaccine.
Site of injection on my arm is still causes pain 8 weeks later. Damage seems to be to my tricep muscle. Pain is primarily experienced when I move my arm a certain way but sometimes experienced when my arm is still. My personal trainer who I see weekly is a licensed physical therapist and has been working on this for 6 weeks but the pain is persisting.
Received the flu vaccine on August 30, 2020 from the pharmacist on duty. Initially did not have any reaction, but after about two hours of being home, did have pain in the right arm and into the shoulder. Pain continued to worsen, and started to have a clicking in the arm/ shoulder region. When I was unable to take the pain any longer did seek out an orthopedic to evaluate. Have seen the ortho three times now and it is listed as a vaccine related shoulder injury. Have had an injection to assist with pain and physical therapy. MRI tomorrow, and then discussion with the ortho as to where we go from here. Pain is at its worst at night and when I raise my arm above shoulder level.
This spontaneous report as received from a nurse refers to an unspecified patients of unknown age and gender. On an unknown date an unspecified patients received improperly stored RECOMBIVAX HB (route, dose, frequency and lot # not reported). No adverse effects were reported. No further information was provided. This is one of several reports from the same source. Additional information has been requested.
Nauseated; Initial dizziness; Headache; Slight chest pain; This is a spontaneous report from a non-contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205) via an unspecified route of administration in the left arm on 01Apr2021 at 17:15 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines, overweight and high blood pressure (hbp). Known allergies of patient were reported as not applicable. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN), rizatriptan (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN) and ibuprofen (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 17:15, the patient experienced initial dizziness and headache, slight chest pain, decreased over time. On 07Apr2021, the patient woke up dizzy and nauseated to the point that the patient couldn't go to work, still felt dizzy and nauseated if the patient moved quickly, but it had reduced in severity. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether therapeutic measures were taken as a result of the events. The clinical outcome of the events initial dizziness, headache, slight chest pain and nauseated were not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
This spontaneous report concerning a 15 months old female patient was received from a physician via Pfizer (Manufacturer report number: 2016308833) on 27-JUN-2016. No medical history and concurrent conditions were provided. On an unknown date, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) (strength, dose, frequency, route, lot expiration date were not provided) instead of PREVNAR (wrong drug administered). There were no concomitant medications reported. No product quality complain was involved. Additional information has been requested.
Per parent, client developed fever of either 100.5 or 105 degrees. Parent was unsure. Parent states they witnessed convulsive like activity. Parents took child to Hospital ER. Per parent, ER gave child Tylenol. After fever decreased and they were discharged approximately 2 hours after arrival. Today child is not very active. The only other symptom is slight local swelling of thighs.
All night muscles hurt from head to toe, didn't get any sleep-got a little better each day but did take anti-inflammatory. On 11/2-soreness mainly upper trunk-"feels like extremely vigorous workout where muscles fatigued". No fever-numbness-or other symptoms. No visible reaction to (L) deltoid site.
Soreness in left arm,; Tested positive Covid-19; Cough; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive Covid-19), COUGH (Cough) and PAIN IN EXTREMITY (Soreness in left arm,) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced COUGH (Cough). On 24-Jan-2021, the patient experienced COVID-19 (Tested positive Covid-19). On an unknown date, the patient experienced PAIN IN EXTREMITY (Soreness in left arm,). On 20-Jan-2021, COUGH (Cough) outcome was unknown. At the time of the report, COVID-19 (Tested positive Covid-19) and PAIN IN EXTREMITY (Soreness in left arm,) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Started 3-18-21 evening- lethargic, loss of appetite  3-19-21 upon waking- Weakness (extreme) Dizziness (extreme) unable to perform daily activities lethargic nausea
The patient was administered VARIVAX and M-M-R II on 08-JAN-2020. It was also reported that the patient was accidentally administered VARIVAX and M-M-R II again on 20-FEB-2020.; The patient was administered VARIVAX and M-M-R II on 08-JAN-2020. It was also reported that the patient was accidentally administered VARIVAX and M-M-R II again on 20-FEB-2020.; The patient was administered  M-M-R II on 08-JAN-2020. It was also reported that the patient was accidentally administered M-M-R II again on 20-FEB-2020.; The patient was administered  M-M-R II on 08-JAN-2020. It was also reported that the patient was accidentally administered M-M-R II again on 20-FEB-2020.; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, drugs reactions or allergies and concomitant medications were not provided.  On 08-JAN-2020, the patient was vaccinated with one dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot number S012036 with expiration date on 17-APR-2021) and one dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (recombinant human albumin (rHA)) (Lot number S007814 has been verified to be a valid lot number for Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live, expiration date reported as 13-MAR-2021, but upon internal validation established as 14-MAR-2021). It was also reported that the patient accidentally was vaccinated with a second dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot number S025611 with expiration date on 18-AUG-2021) and one dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (rHA) (lot number S014429 with expiration date on 09-MAY-2021) on 20-FEB-2020 (extra dose administered, product administration error, inappropriate schedule of vaccine administered and inappropriate dose of vaccine administered). All the vaccines were administered as prophylaxis (route of administration, and anatomical location were not provided). No additional adverse event information was reported.
This spontaneous report was received from a healthcare worker, concerning a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On an unknown date the patient was vaccinated with a dose of ROTATEQ lot # J004875, expiration date 17-OCT-2014, oral route. Healthcare worker reported an expired ROTATEQ was given to a patient. No adverse effects were noted. Co-suspected and concomitant therapies were not reported. Additional information has been requested.
losing my hair; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date Feb2021 (Batch/Lot number: unknown) as dose number unknown , single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ALOPECIA (non-serious), outcome "unknown", described as "losing my hair".  Additional information: The patient has taken the Pfizer shots starting last February. For a year patient has been losing hair since taking all the required shots. It just falls out. It even like reporters hair was prior to the shots. Now another shot? Really? Reporter cannot justify taking another shot just lose more hair. Reporter truly believes that there was something wrong with the shots. And reporter was not the only person. Reporter would like comments from you because this issue needs to be corrected. Reporter still have hair falling out each day.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Cellulitis down left deltoid approx. 13cm width x 14cm length; red, warm to touch; tx: cold compress to site watch for spreading, BENADRYL as needed. Call office with concerns.
Whole body aches and general tiredness over last 2 days.  Now have slight fever...Took Motrin once at 3am on 3/25 and now taking Tylenol at 4pm on 3/25
Medical assistant calling to report they administer some vaccine past the BUD (17Feb2023) to 20 patients.; no adverse event; This spontaneous case was reported by a medical assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Medical assistant calling to report they administer some vaccine past the BUD (17Feb2023) to 20 patients.) and NO ADVERSE EVENT (no adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Patient did not report any medical history/conditions, allergy, concomitant diseases and risk factor (including any previous COVID-19 diagnosis).     On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Medical assistant calling to report they administer some vaccine past the BUD (17Feb2023) to 20 patients.) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Medical assistant calling to report they administer some vaccine past the BUD (17Feb2023) to 20 patients.) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Medical assistant calling to report they administer some vaccine past the BUD (17Feb2023) to 20 patients.).    Patient did not received any other vaccines in the 4 weeks prior to Covid-19.  No concomitant medications were provided.  The vaccines were administered between 13-Mar-2023 to 05-Jun-2023. Patients received the vaccine either as the 3rd, 4th or 5th dose. Health care professional was looking for the availability of the vaccine.  No treatment medication was provided.  This case contains information for the 5th of 20 adult patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-727707 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-727707:Master case
After receiving the vaccination, patient reported that she felt light headed .  Symptoms did resolve about 5 minutes after vaccination.
after 20-30 minutes my throat started to get tight, I could not swallow properly, I felt dizzy & my heart was beating fast.
Pt tested positive for covid yesterday and presented to the ED today due to weakness. He admits to occasional dyspnea. Pt has been feeling very fatigued. HX of MS.  He was observed. He remained on room air and was discharged home once stable.
Patient was given vaccines then allowed to leave right after. She felt dizzy upon standing. She sat down in a chair, said she could not see, then passed out. She looked like she was having a mild seizure. Paramedics were called to transport to hospital because she took longer to come to consciousness than expected. Hospital did EKG, blood sugar testing, blood pressure, and determined it was Vasovagal Syncope. Advised her to be hydrated and eat a good breakfast before shots and to sit or lie down for 15 minutes after a shot.
I got my period 2 weeks early even though it is always right on time and never early or late for me in general.  This same issue happened with my 2nd Moderna shot on 04/28/21.  It took about 6 months for my cycle to straighten out last time this occured.
Patient is an 87-year-old woman with a history of scleroderma who lives with her son, who was diagnosed with COVID; the patient is now presenting during evening hours of 10/6/2023 with increasing shortness of breath and lethargy, also tested positive for COVID. She was started on Decadron and Remdesivir, and improved slowly, saturating well on RA, tolerating diet, stable for discharge home today.   COVID pneumonitis Acute hypoxic respiratory failure- resolved - Presented with: Shortness of breath, weakness - Symptom onset: 48 hours prior to arrival increasing in a crescendo fashion - Positive COVID-19: 10/6/2023 at RMH - Vaccination status: Pfizer, x3 in 2021 - CXR on admission showed mild atelectasis - Oxygen status: initially required 2L/min, now on RA - Decadron: Yes. Expected end date 10/16/2023; holding patient's home methylprednisolone until finishing Decadron - Remdesivir: Yes. Received until 10/10 - DVT prophylaxis: Heparin   Paroxysmal Atrial fibrillation - Seen in atrial fibrillation clinic December 2021 and managing conservatively with rate control, although rates have been stable and no need for meds - Not on AC due to history of bleeding risk, on aspirin   Scleroderma  - Known hx of w/ limited cutaneous SSc reported & CREST symptoms identified - Home regimen: hydroxychloroquine/methylprednisolone for immunosuppressive tx; holding plaquenil d/t interaction with remdesivir, holding methylpred with current decadron - resume at discharge - No PAH noted on TTE (10/2017) w/ outpt follow up per Rheum   HFpEF - Abnormal diastolic filling noted TTE (10/2017) w/o evidence of acute HF present - Underlying scleroderma and HTN the reported etiology   Protein calorie malnutrition GERD - BMI 16 w/ diffuse muscle wasting and increased fatigue reported - Continue to encourage PO intake and supplements  - Continue Pepcid   Essential hypertension - Known hx w/ component of scleroderma and BP controlled - Continue amlodipine with hold parameters   Recurrent major depressive disorder, in partial remission - Known hx w/o symptoms of geriatric depression identified - Continue sertraline @ this time and review for continued need for medical tx by PCP recommended   Hyperlipidemia - Continue simvastatin Fibromuscular dysplasia - Bilateral status post brachial artery bypass grafting with bilateral digital ischemia - Fall precautions notably when using an assist device   Adult failure to thrive syndrome - Chronic impaired mobility d/t multi-joint OA, MSK contractures and scleroderma changes - PT/OT recommends ECF, but patient and family opting to go home with HHS
This spontaneous report as received from a registered nurse refers to an adult patient of unknown age and gender. On 25-JUL-2013 the patient was vaccinated with an expired dose of M-M-R II, (lot number reported as 0870AA, Expiration date 06-JUN-2013), dose, route and anatomical location unspecified. Concomitant medications were not reported. No adverse effects were reported. Additional information has been requested.
This spontaneous report was received from an office manager and refers to a 4 year-old patient of unknown gender. There was no information about patient's concomitant medications, concurrent conditions or pertinent medical history reported. On 25-OCT-2016, the patient was vaccinated with the first improperly stored dose of VARIVAX, lot number M027885 with an expiration date on 30-JUN-2018 (dose, route and anatomical location was not reported) for prophylaxis. The vaccine was exposed to temperature of 7.7 Fahrenheit (F) during 24 hours. There was no previous temperature excursion. No adverse effects were reported. No data logger was involved. This is one of several reports from the same source. Additional information has been requested.; Sender's Comments: US-009507513-1704USA004460: US-009507513-1704USA004461: US-009507513-1704USA004462: US-009507513-1704USA004463: US-009507513-1704USA004464: US-009507513-1704USA004465: US-009507513-1704USA004466: US-009507513-1704USA004467: US-009507513-1704USA004468: US-009507513-1704USA004469: US-009507513-1704USA004471: US-009507513-1704USA004472: US-009507513-1704USA004473: US-009507513-1704USA004474: US-009507513-1704USA004475: US-009507513-1704USA004476: US-009507513-1704USA004477: US-009507513-1704USA004478: US-009507513-1704USA004479: US-009507513-1704USA004480: US-009507513-1704USA004481: US-009507513-1704USA004482: US-009507513-1704USA004483: US-009507513-1704USA004484: US-009507513-1704USA004485: US-009507513-1704USA004486: US-009507513-1704USA004487: US-009507513-1704USA004488: US-009507513-1704USA004489: US-009507513-1704USA004490: US-009507513-1704USA004491: US-009507513-1704USA004492: US-009507513-1704USA004493: US-009507513-1704USA004494: US-009507513-1704USA004495: US-009507513-1704USA004496: US-009507513-1704USA004497: US-009507513-1704USA004498: US-009507513-1704USA004499: US-009507513-1704USA004500: US-009507513-1704USA004501: US-009507513-1704USA004502: US-009507513-1704USA004503: US-009507513-1704USA004504: US-009507513-1704USA004505: US-009507513-1704USA004506: US-009507513-1704USA004507: US-009507513-1704USA004508: US-009507513-1704USA004509: US-009507513-1704USA004510: US-009507513-1704USA004511: US-009507513-1704USA004512: US-009507513-1704USA004513: US-009507513-1704USA004514: US-009507513-1704USA004515: US-009507513-1704USA004516: US-009507513-1704USA004517: